U.S. Journalist and Media Contact Information

The contacts listed below are for use by representatives of the news media. If you are not a member of the media and need assistance, we ask that you please contact the company at 1-800-243-0127, Monday through Friday from 8:30 a.m. to 5:00 p.m., excluding holidays.

This contact information is not intended for reporting unexpected drug effects or adverse events for any Boehringer Ingelheim product. Please report any unexpected effects or product problems to the Drug Information Unit by calling 1-800-542-6257 (option 4).

US Headquarters Contact Information

  • Boehringer Ingelheim Pharmaceuticals, Inc.

    900 Ridgebury Rd.
    P.O. Box 368
    Ridgefield, CT 06877

U.S. Corporate Media Inquiries

  • Media Contact - Public Affairs & Communications

    Amy Kunkel

    Boehringer Ingelheim Pharmaceuticals, Inc

U.S. Products and Pipeline Media Inquiries - General

  • Media Contact - U.S. Prescription Medicines, Therapeutic Areas & Pipeline

    Kate O'Connor

    Boehringer Ingelheim Pharmaceuticals, Inc

U.S. Products by Therapeutic Area

  • Media Contact - Cardiovascular & Diabetes

    Lara Crissey

    Type II Diabetes

    Atrial Fibrillation

  • Media Contact - Diabetes

    Susan Holz

    Type II Diabetes

  • Media Contact - Cardiovascular

    Anna Moses

    Aggrenox® (aspirin/ extended-release dipyridamole) capsules

    Micardis® (telmisartan) tablets

    Pradaxa® (dabigatran etexilate mesylate) capsules
    Stroke Prevention in Atrial Fibrillation

  • Media Contact - Central Nervous System

    Kate O'Connor

    Mirapex® (pramipexole) tablets

  • Media Contact - HIV and Hepatitis C Virus

    Jennifer Soares

    Aptivus® (tipranavir) capsules

    Viramune® (nevirapine) tablets

  • Media Contact - Oncology

    Jennifer A. Soares

    Non-Small Cell Lung Cancer (NSCLC)

  • Media Contact - Respiratory

    Emily Baier

    Atrovent® HFA (ipratropium bromide HFA) Inhalation Aerosol

    Combivent® (ipratropium bromide and albuterol sulfate)

    Spiriva® HandiHaler® (tiotropium bromide inhalation powder)

    Chronic Obstructive Pulmonary Disease (COPD)

    DRIVE4COPD

U.S. Consumer Health Care Inquiries

  • Media Contact - Consumer Health Care

    Susan Holz

    Boehringer Ingelheim Pharmaceuticals, Inc

International Contact

  • Our Vision
    Boehringer Ingelheim GmbH

    Corporate Division Communications
    Binger Strasse 173
    D-55216 Ingelheim am Rhein
    Germany